TITLE

Gene expression signature of estrogen receptor α status in breast cancer

AUTHOR(S)
Abba, Martín C; Yuhui Hu; Hongxia Sun; Drake, Jeffrey A; Gaddis, Sally; Baggerly, Keith; Sahin, Aysegul; Aldaz, C Marcelo
PUB. DATE
January 2005
SOURCE
BMC Genomics;2005, Vol. 6, p37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Estrogens are known to regulate the proliferation of breast cancer cells and to modify their phenotypic properties. Identification of estrogen-regulated genes in human breast tumors is an essential step toward understanding the molecular mechanisms of estrogen action in cancer. To this end we generated and compared the Serial Analysis of Gene Expression (SAGE) profiles of 26 human breast carcinomas based on their estrogen receptor α (ER) status. Thus, producing a breast cancer SAGE database of almost 2.5 million tags, representing over 50,000 transcripts. Results: We identified 520 transcripts differentially expressed between ERα-positive (+) and ERα-negative (-) primary breast tumors (Fold change 2; p < 0.05). Furthermore, we identified 220 high-affinity Estrogen Responsive Elements (EREs) distributed on the promoter regions of 163 out of the 473 up-modulated genes in ERα (+) breast tumors. In brief, we observed predominantly up-regulation of cell growth related genes, DNA binding and transcription factor activity related genes based on Gene Ontology (GO) biological functional annotation. GO terms over-representation analysis showed a statistically significant enrichment of various transcript families including: metal ion binding related transcripts (p = 0.011), calcium ion binding related transcripts (p = 0.033) and steroid hormone receptor activity related transcripts (p = 0.031). SAGE data associated with ERα status was compared with reported information from breast cancer DNA microarrays studies. A significant proportion of ERα associated gene expression changes was validated by this cross-platform comparison. However, our SAGE study also identified novel sets of genes as highly expressed in ERα (+) invasive breast tumors not previously reported. These observations were further validated in an independent set of human breast tumors by means of real time RT-PCR. Conclusion: The integration of the breast cancer comparative transcriptome analysis based on ERα status coupled to the genome-wide identification of high-affinity EREs and GO over-representation analysis, provide useful information for validation and discovery of signaling networks related to estrogen response in this malignancy.
ACCESSION #
28858478

 

Related Articles

  • Interplay of Genes Regulated by Estrogen and Diindolylmethane in Breast Cancer Cell Lines. Mulvey, Laura; Chandrasekaran, Alamelu; Kai Liu; Lombardi, Sarah; Xue-ping Wang; Auborn, Karen J.; Goodwin, Leslie // Molecular Medicine;Jan/Feb2007, Vol. 13 Issue 1/2, p69 

    Dilndolylmethane (DIM), a biologically active congener of indole-3-carbinol (13C) derived from cruciferous vegetables, is a promising agent for the prevention of estrogen-sensitive cancers, Both DIM and estrogen affect transcription of genes by binding receptors, such as aryl hydrocarbon...

  • The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells.  // Cell Communication & Signaling;2012, Vol. 10 Issue 1, p18 

    The article presents a study which analyzes the requirement for MEK Partner 1 (MP1) expression in estrogen receptor (ER) positive breast cancer cells. It notes that inhibition of the expression of MP1 using siRNA duplexes caused detachment and apoptosis of various ER-positive breast cancer cell...

  • Curcumin inhibit leptin gene expression and secretion in breast cancer cells by estrogen receptors. Nejati-Koshki, Kazem; Akbarzadeh, Abolfazl; Pourhassan-Moghaddam, Mohammad; Sang Woo Joo; Hanifepour, Younes // Cancer Cell International;2014, Vol. 14 Issue 1, p1 

    Background: Recent studies suggested that leptin as a mitogenic factor might play an important role in the process of initiation and progression of human cancer. Therefore, it could be considered as a target for breast cancer therapy. A previous study has showed that expression of leptin gene...

  • ß-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells. Gupta, Nibedita; Schmitt, Fee; Grebhardt, Sina; Mayer, Doris // Cancers;2011, Vol. 3 Issue 3, p2990 

    Estrogen receptor-alpha (ERα) is a key factor in the development of breast cancer in humans. The expression and activity of ERα is regulated by a multitude of intracellular and extracellular signals. Here we show a cross-talk between β-catenin and ERα in human breast cancer cells....

  • Role of estrogen receptor in breast cancer cell gene expression. YABING ZHENG; XIYING SHAO; YUAN HUANG; LEI SHI; BO CHEN; XIAOJIA WANG; HONGJIAN YANG; ZHANHONG CHEN; XIPING ZHANG // Molecular Medicine Reports;2016, Vol. 13 Issue 5, p4046 

    The aim of the present study was to establish the underlying regulatory mechanism of estrogen receptor (ER) in breast cancer cell gene expression. A gene expression profile (accession no. GSE11324) was downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes...

  • Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Ellison-Zelski, Stephanie J.; Alarid, Elaine T. // Molecular Cancer;2010, Vol. 9, p263 

    Background: Sin3A is an evolutionarily conserved transcriptional repressor which regulates gene expression as part of the multi-protein Sin3 repressive complex. It functions as a scaffold upon which proteins with enzymatic activity dock, including chromatin modifying histone deacetylases....

  • Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells. D'Anello, Laura; Sansone, Pasquale; Storci, Gianluca; Mitrugno, Valentina; D'Uva, Gabriele; Chieco, Pasquale; Bonafé, Massimiliano // Molecular Cancer;2010, Vol. 9, p300 

    Background: Basal-like carcinoma are aggressive breast cancers that frequently carry p53 inactivating mutations, lack estrogen receptor-a (ERα) and express the cancer stem cell markers CD133 and CD44. These tumors also over-express Interleukin 6 (IL-6), a pro-inflammatory cytokine that...

  • Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation. Maruani, D M; Spiegel, T N; Harris, E N; Shachter, A S; Unger, H A; Herrero-González, S; Holz, M K // Oncogene;12/6/2012, Vol. 31 Issue 49, p5073 

    The 40S ribosomal S6 kinase 1 (S6K1) is an important regulator of cell growth. Expression of S6K1 is often elevated in breast cancer cells. However, the transcriptional mechanism of S6K1 overexpression is not understood. In this report, we demonstrate that estrogen activates expression of S6K1...

  • Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells. Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Estrogen is implicated as an important factor in stimulating breast cancer cell proliferation, and presence of estrogen receptor (ER) is an indication of a good prognosis in breast cancer patients. Mcl-1 is an anti-apoptotic Bcl-2 family member that is often over expressed in breast tumors,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics